Abstract:
Objective: To evaluate the effectiveness of pulse therapy for peripheral vascular lesions in systemic scleroderma. Material and methods: 57 patients diagnosed with
systemic scleroderma (according to the ACR/EULAR classification) with the onset of the disease from 1 year to 5
years, receiving pulse therapy, were observed. Results:
In patients with systemic scleroderma, pulse therapy was
used in combination with basic therapy. Complications
that may occur in patients can be prevented by selecting
adequate doses and timely pulse therapy. Conclusions:
When using pulse therapy, improvement in the general
condition and remission in patients occurs in a shorter
time than in patients who received only basic therapy.
